43.62
price down icon1.03%   -0.455
after-market アフターアワーズ: 43.62
loading

Exelixis Inc (EXEL) 最新ニュース

pulisher
Jun 18, 2025

Here's Why Exelixis (EXEL) is a Strong Value Stock - Yahoo Finance

Jun 18, 2025
pulisher
Jun 14, 2025

How to Take Advantage of moves in (EXEL) - news.stocktradersdaily.com

Jun 14, 2025
pulisher
Jun 14, 2025

Exelixis’s SWOT analysis: cabozantinib’s strength, zanzalintinib’s potential drive stock outlook - Investing.com Canada

Jun 14, 2025
pulisher
Jun 13, 2025

Zacks.com featured highlights include Flex, CVS Health, Urban Outfitters and Exelixis - Yahoo Finance

Jun 13, 2025
pulisher
Jun 12, 2025

EXEL: HC Wainwright & Co. Raises Price Target to $47.00 | EXEL S - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Exelixis stock maintains buy rating at H.C. Wainwright on promising data - Investing.com Canada

Jun 12, 2025
pulisher
Jun 12, 2025

Why Is Exelixis (EXEL) Down 7.2% Since Last Earnings Report? - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Exelixis, Inc.'s (NASDAQ:EXEL) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - simplywall.st

Jun 12, 2025
pulisher
Jun 12, 2025

EXEL: HC Wainwright & Co. Raises Price Target to $47.00 | EXEL Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Exelixis (EXEL) Stock Target Boosted by H.C. Wainwright | EXEL S - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Promising Clinical Data and Favorable Safety Profile Drive Buy Rating for Exelixis - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Exelixis (EXEL) Stock Target Boosted by H.C. Wainwright | EXEL Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 10, 2025

Indexes Rise But Growth Plays Hit; Quanta Services, Exelixis, Google In Focus - Investor's Business Daily

Jun 10, 2025
pulisher
Jun 09, 2025

Kalkine: Exelixis Joins Momentum Wave Ahead of Russell 1000 Rebalance - Kalkine Media

Jun 09, 2025
pulisher
Jun 09, 2025

BofA Hikes Exelixis, Inc. (EXEL) Target Amid CRC Caution - MSN

Jun 09, 2025
pulisher
Jun 09, 2025

3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL) - Yahoo Finance

Jun 09, 2025
pulisher
Jun 09, 2025

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth - DirectorsTalk Interviews

Jun 09, 2025
pulisher
Jun 09, 2025

Exelixis, Inc. (NASDAQ:EXEL) Stock Holdings Increased by GAMMA Investing LLC - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Bank of America Forecasts Strong Price Appreciation for Exelixis (NASDAQ:EXEL) Stock - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Brokerages Set Exelixis, Inc. (NASDAQ:EXEL) Price Target at $38.94 - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Zacks Research Has Bullish Forecast for Exelixis Q2 Earnings - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Exelixis Escapes Cancer Drug Invalidity Bid At PTAB - Law360

Jun 06, 2025
pulisher
Jun 06, 2025

Are You Looking for a Top Momentum Pick? Why Exelixis (EXEL) is a Great Choice - Yahoo Finance

Jun 06, 2025
pulisher
Jun 05, 2025

Analyst Expectations For Exelixis's Future - Benzinga

Jun 05, 2025
pulisher
Jun 05, 2025

Exelixis (EXEL) Sees Price Target Raised by B of A Securities | - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

BofA Adjusts Price Target for Exelixis (EXEL) Amid Critical Pipe - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Director Jack Wyszomierski Sells 7,535 Shares of Exelixis Inc (E - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

Director Jack Wyszomierski Sells 7,535 Shares of Exelixis Inc (EXEL) - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Exelixis at Jefferies Conference: Strategic Moves for Growth By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

Exelixis Stock Surges 28% YTD: Should You Buy Now or Sell? - sharewise

Jun 04, 2025
pulisher
Jun 04, 2025

Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term - sharewise

Jun 04, 2025
pulisher
Jun 04, 2025

Transcript : Exelixis, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 07 - MarketScreener

Jun 04, 2025
pulisher
Jun 03, 2025

Exelixis Stock Surges 28% YTD: Should You Buy Now Or Sell? - Barchart.com

Jun 03, 2025
pulisher
Jun 03, 2025

Stifel maintains hold rating on Exelixis stock, sets $38 target - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Exelixis at 45th Annual William Blair Conference: Oncology Ambitions - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

Transcript : Exelixis, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10 - MarketScreener

Jun 03, 2025
pulisher
Jun 02, 2025

Here's Why Exelixis (EXEL) is a Strong Growth Stock - Yahoo Finance

Jun 02, 2025
pulisher
Jun 02, 2025

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Growth in the Biotech Space with Robust Revenue Momentum - DirectorsTalk Interviews

Jun 02, 2025
pulisher
May 31, 2025

Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ASCO 2025 - Business Wire

May 31, 2025
pulisher
May 30, 2025

2 Top Stocks to Buy With Less Than $100 - The Globe and Mail

May 30, 2025
pulisher
May 28, 2025

Why Exelixis (EXEL) is a Top Value Stock for the Long-Term - Yahoo Finance

May 28, 2025
pulisher
May 27, 2025

Transcript : Exelixis, Inc. Presents at TD Cowen's 6th Annual Oncology Innovation Summit, May-27-2025 02 - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Decreases Stake in Exelixis, Inc. (NASDAQ:EXEL) - Defense World

May 27, 2025
pulisher
May 26, 2025

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with Promising Growth Potential - DirectorsTalk Interviews

May 26, 2025
pulisher
May 25, 2025

EXEL Reports Superior Efficacy Data From Kidney Cancer Study Cohort - MSN

May 25, 2025
pulisher
May 25, 2025

Exelixis’s SWOT analysis: stock poised for growth amid oncology pipeline progress By Investing.com - Investing.com South Africa

May 25, 2025
pulisher
May 25, 2025

Exelixis’s SWOT analysis: stock poised for growth amid oncology pipeline progress - Investing.com Australia

May 25, 2025
pulisher
May 25, 2025

Deutsche Bank AG Has $1.54 Million Stake in Exelixis, Inc. (NASDAQ:EXEL) - Defense World

May 25, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
大文字化:     |  ボリューム (24 時間):